top of page
Abstract Line Pattern

Lung Cancer (SCLC - Small Cell Lung Cancer)

Lung Cancer (SCLC - Small Cell Lung Cancer)

(EVOKE-SCLC-04) A Global, Multicenter, Randomized, Open-label, Phase 3 Study of Sacituzumab Govitecan Versus Standard of Care (SOC) in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer (ES-SCLC)

Principal Investigator (PI)

Clinical Trials.gov ID

Key Eligibility

Protocol #

SPONSOR

Gilead Sciences
bottom of page